Ramipril STADA is not recommended for use in children and adolescents under 18 years of age as its safety and efficacy have not yet been established in this population.If any of the above applies (or you are unsure), speak with your doctor before taking Ramipril STADA.
Taking Ramipril STADA with other medications:
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medication.
This is because Ramipril STADA may affect the way some other medications work. Similarly, some medications may affect the way Ramipril STADA works.
Inform your doctor if you are taking any of the following medications, which may make Ramipril STADA work less effectively:
Inform your doctor if you are taking any of the following medications. These may increase the likelihood of adverse effects if taken with Ramipril STADA:
· Temsirolimus (for cancer)
· Sirolimus, everolimus (for organ transplant rejection prevention)
· Vildagliptina (used to treat type 2 diabetes)
·Your doctor may need to change your dose and/or take other precautions if you are taking any angiotensin II receptor blocker (ARA II) or aliskiren (see also the information in the sections "Do not take Ramipril STADA" and "Warnings and precautions".
Inform your doctor if you are taking any of the following medications. Since these may be affected by Ramipril STADA:
In particular, speak with your doctor or pharmacist if you are taking, have taken recently or may need to take any of the following medications:
If any of the above applies to you (or you are unsure), speak with your doctor before taking Ramipril STADA.
Taking Ramipril STADA with food, drinks and alcohol
Pregnancy and breastfeeding
Pregnancy
Inform your doctor if you think you may be pregnant (or intend to become pregnant).
You should not take Ramipril STADA during the first 12 weeks of pregnancy, and in any case, you should not take it from the 13th week onwards, as its use during pregnancy may harm your baby. If you become pregnant during treatment with Ramipril STADA, inform your doctor immediately. If you plan to become pregnant, your doctor will change your treatment.
Breastfeeding
You should not take Ramipril STADA if you are breastfeeding.
Consult your doctor or pharmacist before using any medication.
Driving and operating machines
You may feel dizzy while taking Ramipril STADA, which is more likely to occur when starting to take Ramipril STADA or when starting a higher dose. If this occurs, do not drive or operate tools or machines.
Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again if you have any doubts.
How much medication to take
Hypertension treatment
To reduce the risk of suffering a heart attack or stroke
Treatment to reduce or delay the worsening of kidney problems
Heart failure treatment
Treatment after having had a heart attack
Older patients
Your doctor will reduce the initial dose and adjust your treatment more slowly.
Take this medication
If you take more Ramipril STADA than you should
Consult your doctor immediately or go to the nearest hospital emergency room, accompanied by this leaflet or call the Toxicological Information Service (phone 91-562.04.20).
Do not drive to the hospital, ask someone to take you or call an ambulance. Bring the medication packaging with you. This way, your doctor will know what you have taken.
If you forgot to take Ramipril STADA
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Ramipril STADA can cause side effects, although not everyone will experience them.
Stop taking Ramipril STADA and seek immediate medical attention if you notice any of the following severe side effects - you may need urgent medical treatment:
Inform your doctor immediately if you experience:
Other side effects include:
Inform your doctor if any of the following side effects worsen or last more than a few days.
Frequent
(can affect up to 1 in 10 people)
Rare(can affect up to 1 in 100 people)
Very rare
(can affect up to 1 in 10,000 people)
Frequency not known
If you have these symptoms, consult your doctor as soon as possible.
Other side effects reported:
Inform your doctor if any of the following conditions worsen or last more than a few days.
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it's a possible side effect that doesn't appear in this leaflet. You can also report them through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of reach and sight of children.
Do not use Ramipril STADA after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of RamiprilSTADA
Each tablet contains 5 mg oframipril
Appearance of the product and contents of the package
RamiprilSTADA5 mg are yellowish pale to yellow speckled tablets, with a size of 8.1x4,1x3.15 mm, oval, engraved with the letter “R” and the number “19” on each side of the groove on one face and also with a groove on the other.
The tablet can be divided into two equal halves.
The RamiprilSTADAtablets are presented in the following packages:
Blister of formation in freeze-dried (OPA/Alu/PVC/Alu) and blister of formation in freeze-dried with desiccant (OPA/Alu/PE/Desiccant/HDPE/ Alu).
Packaging sizes:
RamiprilSTADA5 mg:14, 28, 30, 56, 90or100 tablets
Only some packaging sizes may be commercially available.
Marketing authorization holder and responsible for manufacturing
Marketing authorization holder
STADA,S.L.
FredericMompou,5
08960SantJustDesvern(Barcelona)
[email protected]
Responsible for manufacturing
Terapia SA
Str. Fabricii nr. 124, Cluj Napoca 400 632
Romania
or
Sun Pharmaceutical Industries Europe B.V.,
Polarisavenue 87,
2132 JH Hoofddorp
Netherlands
Last review date of the leaflet: May 2019
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.